| Lakes Blue Energy NL (LKO) ORDINARY FULLY PAID |
Energy |
$86 |
Wombat-5 Well, Gippsland Basin - Production Testing Update
|
14 Jan 2026 9:18AM |
$1.305 |
$1.170 |
fallen by
10.34%
|
|
| Qantas Airways Limited (QAN) ORDINARY FULLY PAID |
Industrials |
$15,949 |
Notification of cessation of securities - QAN
|
14 Jan 2026 9:17AM |
$10.200 |
$10.540 |
risen by
3.33%
|
|
| Austral Resources Australia Ltd (AR1) ORDINARY FULLY PAID |
Materials |
$50 |
MOU for Toll Treatment of Ore at Rocklands
|
14 Jan 2026 9:17AM |
$0.110 |
$0.094 |
fallen by
14.55%
|
|
| Enlitic Inc (ENL) CHESS DEPOSITARY INTERESTS 1:1 US PROHIBITED |
Health Care |
$7 |
Notification of cessation of securities - ENL
|
14 Jan 2026 9:17AM |
$0.019 |
$0.009 |
fallen by
52.63%
|
|
| Pengana Private Equity Trust (PE1) ORDINARY UNITS FULLY PAID |
Financials |
$388 |
Update - Notification of buy-back - PE1
|
14 Jan 2026 9:17AM |
$1.370 |
$1.450 |
risen by
5.84%
|
|
| Resolution Minerals Ltd (RML) ORDINARY FULLY PAID |
Materials |
$87 |
Further Ultra High Grade Antimony and Silver Results
|
14 Jan 2026 9:15AM |
$0.056 |
$0.043 |
fallen by
23.21%
|
|
RML - Price-sensitive ASX Announcement
Full Release
Key Points
- Outstanding antimony and silver grades from five massive stibnite samples.
- The five rock samples averaged 39.2% Sb and 430 g/t Ag.
- Results support and extend prior sampling, delineating a broad mineralized footprint.
- Antimony Ridge has a large, consistently mineralized area of Sb, Au, and Ag.
- Antimony grades of this magnitude are rarely reported globally.
- Metallurgical test work and permitting for drilling and bulk sampling are underway.
- The Horse Heaven Project is strategically significant for U.S. antimony supply.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Whitefield Industrials Limited (WHF) ORDINARY FULLY PAID |
Financials |
$634 |
Net Tangible Asset Backing - Dec 25
|
14 Jan 2026 9:15AM |
$5.410 |
$5.250 |
fallen by
2.96%
|
|
| Enlitic Inc (ENL) CHESS DEPOSITARY INTERESTS 1:1 US PROHIBITED |
Health Care |
$7 |
Notification regarding unquoted securities - ENL
|
14 Jan 2026 9:14AM |
$0.019 |
$0.009 |
fallen by
52.63%
|
|
| Diablo Resources Limited (DBO) ORDINARY FULLY PAID |
Materials |
$6 |
High Grade Silver and Antimony Results
|
14 Jan 2026 9:14AM |
$0.025 |
$0.024 |
fallen by
4%
|
|
DBO - Price-sensitive ASX Announcement
Full Release
Key Points
- High-grade silver, antimony, and copper systems confirmed at Star Range Project.
- New prospect areas identified: East Star, West Star, and Silver Gulch.
- North Star Prospect is a priority drill target with significant mineralisation.
- Peak assay results include 880 g/t Ag, 9.3 g/t Au, 0.6% Sb, and 2.6% Cu.
- Project located in Utah, USA, with excellent infrastructure and nearby historical mines.
- Drill targeting is well advanced, with geophysical data integration ongoing.
- Exploration efforts focus on extending mineralised trends and defining new targets.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Flight Centre Travel Group Limited (FLT) ORDINARY FULLY PAID |
Consumer Discretionary |
$2,933 |
Update - Notification of buy-back - FLT
|
14 Jan 2026 9:12AM |
$15.030 |
$13.800 |
fallen by
8.18%
|
|
| Morphic Ethical Equities Fund Limited (MEC) ORDINARY FULLY PAID |
Financials |
$37 |
Update - Notification of buy-back - MEC
|
14 Jan 2026 9:10AM |
$1.185 |
$1.195 |
risen by
0.84%
|
|
| Prospect Resources Limited (PSC) ORDINARY FULLY PAID |
Materials |
$292 |
Widespread gold identified at Nyungu Central
|
14 Jan 2026 9:09AM |
$0.345 |
$0.410 |
risen by
18.84%
|
|
PSC - Price-sensitive ASX Announcement
Full Release
Key Points
- 32 holes drilled, 26 with significant gold grades.
- 30m at 0.21g/t Au from 187m, within 30m at 0.79% Cu.
- Maiden gold resource estimate in development.
- Potential economic upgrade for the Mumbezhi Project.
- Further assay results expected by January 2026.
- MRE updates scheduled for late Q1 2026.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| L1 Global Long Short Fund Limited (GLS) ORDINARY FULLY PAID |
Financials |
$1,064 |
Weekly Net Tangible Asset Backing
|
14 Jan 2026 9:09AM |
$1.765 |
$1.945 |
risen by
10.20%
|
|
| Dalaroo Metals Ltd (DAL) ORDINARY FULLY PAID |
Materials |
$20 |
Trading Halt
|
14 Jan 2026 9:09AM |
$0.054 |
$0.060 |
risen by
11.11%
|
|
DAL - Price-sensitive ASX Announcement
Full Release
Key Points
- Trading halt requested by Dalaroo Metals Ltd.
- Pending announcement of exploration results from Blue Lagoon Project in Greenland.
- Trading halt effective from 14 January 2026.
- Halt to end on 16 January 2026 or upon release of the announcement.
- No known reasons against granting the trading halt.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Rimfire Pacific Mining Limited (RIM) ORDINARY FULLY PAID |
Materials |
$44 |
Notification of cessation of securities - RIM
|
14 Jan 2026 9:09AM |
$0.017 |
$0.016 |
fallen by
5.88%
|
|
| New Zealand King Salmon Investments Limited (NZK) ORDINARY FULLY PAID FOREIGN EXEMPT NZX |
Consumer Staple |
$91 |
SPH Notice - China Resources Asset Management Limited
|
14 Jan 2026 9:08AM |
$0.180 |
$0.170 |
fallen by
5.56%
|
|
| New Zealand King Salmon Investments Limited (NZK) ORDINARY FULLY PAID FOREIGN EXEMPT NZX |
Consumer Staple |
$91 |
SPH Notice - China Resources Enterprise, Limited
|
14 Jan 2026 9:07AM |
$0.180 |
$0.170 |
fallen by
5.56%
|
|
| Predictive Discovery Ltd (PDI) ORDINARY FULLY PAID |
Materials |
$2,490 |
Court Approves Robex Plan of Arrangement
|
14 Jan 2026 9:05AM |
$0.885 |
$0.945 |
risen by
6.78%
|
|
PDI - Price-sensitive ASX Announcement
Full Release
Key Points
- Predictive Discovery Limited (PDI) announced that Robex Resources Inc. received court approval for a plan of arrangement.
- PDI, through its subsidiary, will acquire all common shares of Robex.
- The arrangement was approved by Robex shareholders prior to the court decision.
- Closing of the transaction requires additional approvals from the Governments of Guinea and Mali.
- The transaction is expected to close in Q1 2026.
- This announcement was authorized by the PDI Board.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Robex Resources Inc. (RXR) CHESS DEPOSITARY INTERESTS 1:1 |
Materials |
$2,040 |
PDI: Court Approves Robex Plan of Arrangement
|
14 Jan 2026 9:05AM |
$6.890 |
$7.380 |
risen by
7.11%
|
|
RXR - Price-sensitive ASX Announcement
Full Release
Key Points
- Robex Resources Inc. received court approval for the plan of arrangement.
- Predictive Discovery Limited to acquire all Robex shares.
- Arrangement approved by Robex shareholders on 30 December 2025.
- Transaction completion pending regulatory consents from Guinea and Mali.
- Expected transaction closure in Q1 2026.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Micro-X Limited (MX1) ORDINARY FULLY PAID |
Health Care |
$52 |
MX1 - Notice Under Section 708A(5) of the Corporations Act
|
14 Jan 2026 9:05AM |
$0.086 |
$0.072 |
fallen by
16.28%
|
|
| Racura Oncology Ltd (RAC) ORDINARY FULLY PAID |
Health Care |
$411 |
Racura Oncology Emory University Collaboration
|
14 Jan 2026 9:04AM |
$2.880 |
$2.260 |
fallen by
21.53%
|
|
RAC - Price-sensitive ASX Announcement
Full Release
Key Points
- Racura Oncology Ltd has commenced a collaboration with Emory University to study (E,E)-bisantrene in osimertinib-resistant EGFR-mutated NSCLC.
- The collaboration is led by Professor Shi-Yong Sun, a world-leader in osimertinib-resistant lung cancer biology.
- Racura has access to Emory’s unique osimertinib-resistant cell and mouse NSCLC models and expertise.
- The program supports the HARNESS-1 clinical trial of (E,E)-bisantrene aimed at delaying or preventing resistance to osimertinib.
- The collaboration seeks to characterise the biology and mechanisms of resistance in EGFRm NSCLC.
- Racura Oncology is aiming to extend progression-free and overall survival in patients by targeting osimertinib-resistant sub-clones.
- Professor Sun’s expertise is pivotal in understanding the biology of impressive efficacy when combining (E,E)-bisantrene with osimertinib.
- The collaboration is expected to produce high-quality, mechanism-informed preclinical data supporting RC220.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Mayne Pharma Group Limited (MYX) ORDINARY FULLY PAID |
Health Care |
$212 |
Final Director's Interest Notice
|
14 Jan 2026 9:04AM |
$3.010 |
$2.615 |
fallen by
13.12%
|
|
| WAM Alternative Assets Limited (WMA) ORDINARY FULLY PAID |
Financials |
$202 |
December 2025 Investment Update
|
14 Jan 2026 9:02AM |
$1.030 |
$1.025 |
fallen by
0.49%
|
|
| Predictive Discovery Ltd (PDI) ORDINARY FULLY PAID |
Materials |
$2,490 |
RXR: Robex Obtains Final Court Approval for Plan of Arrangem
|
14 Jan 2026 9:01AM |
$0.885 |
$0.945 |
risen by
6.78%
|
|
PDI - Price-sensitive ASX Announcement
Full Release
Key Points
- Robex obtained final court approval for the merger with Predictive Discovery Ltd.
- The merger involves acquiring all issued shares of Robex by Predictive's subsidiary.
- The transaction was approved by Robex shareholders on 30 December 2025.
- Completion expected in Q1 2026, subject to government consents and conditions.
- Robex's key projects are in Mali and Guinea.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Robex Resources Inc. (RXR) CHESS DEPOSITARY INTERESTS 1:1 |
Materials |
$2,040 |
Robex Obtains Final Court Approval for Plan of Arrangement
|
14 Jan 2026 9:01AM |
$6.890 |
$7.380 |
risen by
7.11%
|
|
RXR - Price-sensitive ASX Announcement
Full Release
Key Points
- Robex Resources Inc. merger agreement with Predictive Discovery Limited approved.
- Final court approval received from Québec Superior Court.
- Merger involves acquisition of all Robex shares by Predictive's subsidiary.
- Arrangement approved at Robex's shareholder meeting on December 30, 2025.
- Completion expected in Q1 2026, subject to government consents and other conditions.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.